MoneyWorks4Me

Anuh Pharma - Quaterly Results

09 Feb 2024 Evaluate
The December 2023 quarter revenue stood at Rs. 1721.01 millions, up 24.05% as compared to Rs. 1387.30 millions during the corresponding quarter last year.The Total revenue for the quarter ended December 2023 of  Rs. 191.12  millions  grew by 105.35% from Rs. 93.07 millions.The company reported a good operating profit of 276.49 millions compared to 145.42 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 1721.01 1387.30 24.05 4831.14 3701.77 30.51 5274.86 4866.46 8.39
Other Income 36.57 21.13 73.07 92.76 50.78 82.67 61.15 51.97 17.66
PBIDT 276.49 145.42 90.13 652.03 421.20 54.80 573.90 520.43 10.27
Interest 1.42 0.29 389.66 2.52 1.95 29.23 2.18 9.61 -77.32
PBDT 275.07 145.13 89.53 649.51 419.25 54.92 571.72 510.82 11.92
Depreciation 22.02 24.33 -9.49 63.57 72.93 -12.83 97.00 119.60 -18.90
PBT 253.05 120.80 109.48 585.94 346.32 69.19 474.72 391.22 21.34
TAX 61.93 27.73 123.33 138.94 80.74 72.08 112.91 85.61 31.89
Deferred Tax 6.43 0.13 4846.15 5.84 -2.36 -347.46 -8.29 -9.95 -16.68
PAT 191.12 93.07 105.35 447.00 265.58 68.31 361.81 305.61 18.39
Equity 250.56 250.56 0.00 250.56 250.56 0.00 250.56 250.56 0.00
PBIDTM(%) 16.07 10.48 53.27 13.50 11.38 18.62 10.88 10.69 1.74
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..